2,3-piperidinedicarboxylic acid has been researched along with Retinal Degeneration in 2 studies
2,3-piperidinedicarboxylic acid: effective antagonist at all three types of excitatory amino acid receptors; does not depress responses to acetylcholine or substance P
Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miura, G | 1 |
| Wang, MH | 1 |
| Ivers, KM | 1 |
| Frishman, LJ | 1 |
| Yokoyama, D | 1 |
| Machida, S | 1 |
| Kondo, M | 1 |
| Terasaki, H | 1 |
| Nishimura, T | 1 |
| Kurosaka, D | 1 |
2 other studies available for 2,3-piperidinedicarboxylic acid and Retinal Degeneration
| Article | Year |
|---|---|
Retinal pathway origins of the pattern ERG of the mouse.
Topics: Adaptation, Ocular; Aminobutyrates; Animals; Electroretinography; Excitatory Amino Acid Antagonists; | 2009 |
Pharmacological dissection of multifocal electroretinograms of rabbits with Pro347Leu rhodopsin mutation.
Topics: Aminobutyrates; Animals; Animals, Genetically Modified; Electroretinography; Excitatory Amino Acid A | 2010 |